4//SEC Filing
Pontes Josias 4
Accession 0001415889-22-000197
CIK 0001821323other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:16 PM ET
Size
5.4 KB
Accession
0001415889-22-000197
Insider Transaction Report
Form 4
Pontes Josias
VP, Head of Finance
Transactions
- Award
Stock Option (Right to Buy)
2022-01-03$3.03/sh+65,000$196,950→ 65,000 totalExercise: $3.03Exp: 2032-01-02→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 30% on January 3, 2023 and 70% on January 3, 2024.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001868415
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:16 PM ET
- Size
- 5.4 KB